Competitors
| Companies | Market Cap | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|
|
BeOne Medicines NasdaqGS:ONC |
31,38 B | 71,53% | 5/6 | 19,62% | 23,64% | 43,12% | DOWN |
|
CRISPR Therapeutics NasdaqGM:CRSP |
4,39 B | 30,82% | 2/6 | 1267,38% | 54,84% | 74,86% | DOWN |
|
Oculis Holding NasdaqGM:OCS |
1,46 B | -33,93% | 0/0 | 399,17% | -11,81% | 95,87% | UP |
|
MoonLake Immunotherapeutics NasdaqCM:MLTX |
1,24 B | 0,00% | 0/4 | 0,00% | 0,00% | 58,78% | DOWN |
|
Kuros Biosciences SWX:KURN |
0,86 B | 0,00% | 6/6 | 19,34% | 97,98% | 61,94% | DOWN |
|
Idorsia Ltd SWX:IDIA |
0,77 B | 26,66% | 4/6 | 9,73% | 87,65% | 46,58% | DOWN |
|
Basilea Pharmaceutica SWX:BSLN |
0,65 B | 66,74% | 5/6 | 15,54% | 4,29% | 65,40% | UP |
|
ADC Therapeutics NYSE:ADCT |
0,47 B | -7,66% | 2/3 | -15,68% | -289,93% | 116,22% | UP |
|
AC Immune NasdaqGM:ACIU |
0,27 B | -29,31% | 1/6 | 691,84% | -105,25% | 212,22% | DOWN |
|
VectivBio Holding NasdaqGM:VECT |
0,17 B | 0,00% | 0/0 | 0,00% | 0,00% | -100,00% | UP |
|
Molecular Partners SWX:MOLN |
0,12 B | -32,25% | 2/6 | 100,00% | -378,96% | 176,92% | DOWN |
|
Relief Therapeutics Holding SWX:MMTX |
0,01 B | 42,95% | 0/0 | 0,00% | 0,00% | -100,00% | DOWN |
|
ObsEva OTCPK:OBSE.F |
0,00 B | 225,03% | 1/3 | 0,00% | 0,00% | 0,00% | DOWN |
|
Mymetics OTCPK:MYMX |
0,00 B | 0,00% | 1/2 | 0,00% | 0,00% | 0,00% | DOWN |
